KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Treasury Shares (2016 - 2025)

Quest Diagnostics' Treasury Shares history spans 17 years, with the latest figure at $5.2 billion for Q4 2025.

  • For Q4 2025, Treasury Shares rose 6.65% year-over-year to $5.2 billion; the TTM value through Dec 2025 reached $5.2 billion, up 6.65%, while the annual FY2025 figure was $5.2 billion, 6.65% up from the prior year.
  • Treasury Shares for Q4 2025 was $52.0 million at Quest Diagnostics, up from $51.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $86.0 million in Q1 2021 and bottomed at $1.0 million in Q4 2021.
  • The 5-year median for Treasury Shares is $50.0 million (2023), against an average of $34.6 million.
  • The largest annual shift saw Treasury Shares tumbled 44.47% in 2021 before it soared 49.02% in 2022.
  • A 5-year view of Treasury Shares shows it stood at $3.5 billion in 2021, then skyrocketed by 35.33% to $4.7 billion in 2022, then increased by 3.27% to $4.8 billion in 2023, then grew by 0.64% to $4.9 billion in 2024, then increased by 6.65% to $5.2 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Treasury Shares are $5.2 billion (Q4 2025), $4.9 billion (Q3 2025), and $4.8 billion (Q2 2025).